Sandra A Tsai, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tsai’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A65925 · Current
Licensed to practise in California · since 1998 · expires 2027-11-30 · University of Texas Southwestern Medical School at Dallas.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$28,901
Medicare paid this office $28,901 for 242 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 83 | $7,904 | $75 |
| Return visit (30+ min) | 59 | $4,918 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 55 | $3,355 | $61 |
| Long return visit (40+ min) | 25 | $2,720 | $91 |
| Long return visit (40+ min) | 34 | $2,682 | $61 |
See all 10 services
| Return visit (30+ min) | 83 | $7,904 | $75 |
| Return visit (30+ min) | 59 | $4,918 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 55 | $3,355 | $61 |
| Long return visit (40+ min) | 25 | $2,720 | $91 |
| Long return visit (40+ min) | 34 | $2,682 | $61 |
| Short return visit (20+ min) | 22 | $1,421 | $57 |
| Short return visit (20+ min) | 17 | $856 | $48 |
| Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report | 28 | $364 | $13 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 19 | $300 | $15 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 11 | $195 | $15 |
Who their Medicare patients are
242 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 12% · Women 67% · Also on Medicaid 20% · Health risk score 1.07. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 71% · Coronary heart disease 28% · Diabetes 26% · Cancer 19% · Chronic kidney disease 17% · Depression 15% · Atrial fibrillation 14% · Stroke 11% · Heart failure 10% · COPD 6% · Dementia 5%.
The office billed $211,290, Medicare allowed $43,583 and paid $28,901; for 470 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 242 | 470 | 75 | 1.07 | $211,290 | $28,901 |
| 2023 | 239 | 406 | 74 | 1.02 | $180,853 | $25,587 |
| 2022 | 182 | 366 | 75 | 0.96 | $183,722 | $23,163 |
| 2021 | 180 | 393 | 74 | 1.00 | $189,789 | $25,487 |
| 2020 | 156 | 313 | 74 | 1.05 | $96,519 | $18,405 |
| 2019 | 167 | 338 | 73 | 1.07 | $48,460 | $24,958 |
| 2018 | 162 | 352 | 72 | 1.06 | $55,450 | $26,373 |
| 2017 | 150 | 299 | 72 | 1.08 | $65,421 | $21,966 |
| 2016 | 159 | 323 | 72 | 1.08 | $75,132 | $22,811 |
| 2015 | 171 | 322 | 72 | 1.35 | $69,805 | $21,685 |
| 2014 | 163 | 343 | 72 | 1.15 | $67,856 | $20,677 |
| 2013 | 172 | 390 | 72 | 1.16 | $77,146 | $23,316 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 121 | $9,964 | $59 |
| Long return visit (40+ min) | 45 | $5,303 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 61 | $3,815 | $63 |
| Short return visit (20+ min) | 35 | $1,876 | $48 |
| New patient visit (60+ min) | 12 | $1,740 | $145 |
| Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report | 32 | $526 | $16 |
2022: 5 services
| Return visit (30+ min) | 86 | $8,145 | $61 |
| Long return visit (40+ min) | 50 | $5,170 | $72 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 43 | $2,763 | $64 |
| Short return visit (20+ min) | 47 | $2,522 | $48 |
| New patient visit (60+ min) | 15 | $2,179 | $145 |
2021: 7 services
| Return visit (30+ min) | 91 | $8,299 | $61 |
| Long return visit (40+ min) | 57 | $5,847 | $68 |
| Short return visit (20+ min) | 46 | $2,832 | $51 |
| New patient visit (60+ min) | 16 | $2,143 | $134 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 33 | $1,854 | $56 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,271 | $71 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $955 | $56 |
2020: 7 services
| Return visit (30+ min) | 83 | $8,216 | $66 |
| Short return visit (20+ min) | 34 | $1,577 | $40 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,576 | $143 |
| Long return visit (40+ min) | 22 | $1,456 | $63 |
| Telephone medical discussion with physician, 11-20 minutes | 29 | $1,402 | $39 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,323 | $66 |
| Return visit (30+ min) | 19 | $1,082 | $52 |
2019: 5 services
| Return visit (30+ min) | 113 | $12,703 | $63 |
| Long return visit (40+ min) | 35 | $5,660 | $93 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 22 | $3,105 | $141 |
| New patient visit (60+ min) | 11 | $1,675 | $152 |
| Short return visit (20+ min) | 29 | $1,339 | $41 |
2018: 6 services
| Return visit (30+ min) | 59 | $5,722 | $66 |
| Return visit (30+ min) | 55 | $5,156 | $59 |
| Long return visit (40+ min) | 34 | $4,339 | $94 |
| Long return visit (40+ min) | 28 | $3,836 | $80 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,106 | $140 |
| Short return visit (20+ min) | 27 | $1,290 | $40 |
2017: 6 services
| Return visit (30+ min) | 64 | $6,281 | $60 |
| Long return visit (40+ min) | 35 | $5,255 | $89 |
| Return visit (30+ min) | 25 | $2,990 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $2,909 | $139 |
| Long return visit (40+ min) | 15 | $1,685 | $94 |
| Short return visit (20+ min) | 18 | $776 | $39 |
2016: 6 services
| Return visit (30+ min) | 66 | $7,279 | $60 |
| Return visit (30+ min) | 38 | $3,835 | $63 |
| Long return visit (40+ min) | 23 | $2,775 | $82 |
| New patient visit (60+ min) | 18 | $2,319 | $129 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,927 | $138 |
| Short return visit (20+ min) | 32 | $1,516 | $39 |
2015: 4 services
| Return visit (30+ min) | 113 | $12,277 | $62 |
| Short return visit (20+ min) | 49 | $2,904 | $42 |
| New patient visit (60+ min) | 13 | $1,832 | $141 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,801 | $139 |
2014: 3 services
| Return visit (30+ min) | 98 | $11,472 | $62 |
| Short return visit (20+ min) | 75 | $4,140 | $39 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,617 | $135 |
2013: 3 services
| Return visit (30+ min) | 115 | $14,281 | $61 |
| Short return visit (20+ min) | 68 | $3,859 | $40 |
| New patient visit (45+ min) | 11 | $1,037 | $94 |
Drugs they prescribed that Part D paid
$166,058
Pharmacies billed $166,058 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (24 of 1,774) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
1,542 generic and 211 brand-name prescriptions · $166,058 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 26 | $33,201 | $1,277 |
| Repatha Sureclick | 30 | $23,900 | $797 |
| Atrovent Hfa | 13 | $5,968 | $459 |
| Belsomra | 12 | $5,072 | $423 |
| Nexletol | 11 | $4,378 | $398 |
See all 41 drugs
| Eliquis | 26 | $33,201 | $1,277 |
| Repatha Sureclick | 30 | $23,900 | $797 |
| Atrovent Hfa | 13 | $5,968 | $459 |
| Belsomra | 12 | $5,072 | $423 |
| Nexletol | 11 | $4,378 | $398 |
| Ezetimibe | 64 | $2,141 | $33 |
| Rosuvastatin | 126 | $1,858 | $15 |
| Dexlansoprazole Dr | 11 | $1,650 | $150 |
| Atorvastatin | 158 | $1,584 | $10 |
| Olmesartan-Hydrochlorothiazide | 17 | $1,088 | $64 |
| Amlodipine Besylate | 128 | $1,050 | $8 |
| Ultra-Fine Mini Pen Needle | 14 | $839 | $60 |
| Metoprolol | 30 | $813 | $27 |
| Levothyroxine | 62 | $740 | $12 |
| Eplerenone | 12 | $724 | $60 |
| Azelastine | 16 | $702 | $44 |
| Losartan | 93 | $571 | $6 |
| Olmesartan Medoxomil | 22 | $450 | $20 |
| Lisinopril | 53 | $438 | $8 |
| Losartan-Hydrochlorothiazide | 14 | $437 | $31 |
| Doxazosin Mesylate | 25 | $434 | $17 |
| Pregabalin | 17 | $369 | $22 |
| Pantoprazole | 24 | $359 | $15 |
| Alendronate | 31 | $324 | $10 |
| Albuterol Sulfate Hfa | 14 | $305 | $22 |
| Hydrochlorothiazide | 61 | $259 | $4 |
| Metformin | 48 | $213 | $4 |
| Pravastatin | 17 | $196 | $12 |
| Chlorthalidone | 16 | $195 | $12 |
| Atenolol | 15 | $182 | $12 |
| Carvedilol | 19 | $181 | $10 |
| Oxycodone-Acetaminophen | 11 | $173 | $16 |
| Tamsulosin | 14 | $154 | $11 |
| Trazodone | 43 | $139 | $3 |
| Gabapentin | 20 | $125 | $6 |
| Simvastatin | 18 | $105 | $6 |
| Spironolactone | 21 | $104 | $5 |
| Furosemide | 27 | $101 | $4 |
| Omeprazole | 16 | $90 | $6 |
| Sertraline | 13 | $50 | $4 |
| Clonidine | 12 | $40 | $3 |
Year by year
| 2024 | 1,774 | 200 | 1% (24) | 12% | $166,058 |
| 2023 | 1,770 | 192 | 1% (13) | 14% | $187,575 |
| 2022 | 1,882 | 199 | 1% (15) | 10% | $141,521 |
| 2021 | 1,827 | 209 | 1% (19) | 11% | $145,389 |
| 2020 | 1,706 | 162 | None | None | $130,204 |
| 2019 | 1,932 | 193 | None | None | $156,204 |
| 2018 | 1,752 | 215 | 1% (20) | 14% | $114,754 |
| 2017 | 1,523 | 176 | 2% (24) | 12% | $100,392 |
| 2016 | 1,568 | 168 | 3% (40) | 15% | $92,698 |
| 2015 | 1,383 | 138 | 4% (55) | None | $84,330 |
| 2014 | 1,263 | 114 | 3% (40) | 16% | $72,515 |
| 2013 | 1,241 | 152 | 3% (41) | 16% | $63,528 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 44 drugs
| Eliquis | 34 | $36,571 | $1,076 |
| Repatha Sureclick | 46 | $35,777 | $778 |
| Ozempic | 11 | $13,085 | $1,190 |
| Myrbetriq | 11 | $5,293 | $481 |
| Rosuvastatin | 120 | $2,914 | $24 |
| Atorvastatin | 150 | $2,774 | $18 |
| Ezetimibe | 47 | $1,615 | $34 |
| Doxazosin Mesylate | 23 | $1,496 | $65 |
| Ventolin Hfa | 15 | $1,423 | $95 |
| Losartan | 99 | $1,302 | $13 |
| Amlodipine Besylate | 129 | $1,263 | $10 |
| Olmesartan-Hydrochlorothiazide | 24 | $1,185 | $49 |
| Telmisartan | 16 | $1,054 | $66 |
| Levothyroxine | 55 | $982 | $18 |
| Metoprolol | 27 | $803 | $30 |
| Sure Comfort Pen Needle | 12 | $651 | $54 |
| Gabapentin | 17 | $595 | $35 |
| Losartan-Hydrochlorothiazide | 11 | $561 | $51 |
| Metformin | 50 | $560 | $11 |
| Potassium Chloride | 17 | $553 | $33 |
| Olmesartan Medoxomil | 19 | $553 | $29 |
| Lisinopril | 50 | $549 | $11 |
| Alendronate | 26 | $535 | $21 |
| Simvastatin | 21 | $483 | $23 |
| Hydrochlorothiazide | 54 | $477 | $9 |
| Trazodone | 31 | $373 | $12 |
| Carvedilol | 21 | $351 | $17 |
| Chlorthalidone | 29 | $329 | $11 |
| Clopidogrel | 13 | $329 | $25 |
| Spironolactone | 31 | $296 | $10 |
| Famotidine | 11 | $292 | $27 |
| Zolpidem | 15 | $266 | $18 |
| Oxycodone-Acetaminophen | 12 | $214 | $18 |
| Pantoprazole | 24 | $193 | $8 |
| Nitroglycerin | 11 | $192 | $17 |
| Fluticasone Propionate | 12 | $178 | $15 |
| Atenolol | 12 | $178 | $15 |
| Furosemide | 26 | $173 | $7 |
| Metoprolol | 13 | $168 | $13 |
| Clonidine | 17 | $166 | $10 |
| Metformin Hcl Er | 11 | $164 | $15 |
| Omeprazole | 11 | $160 | $15 |
| Pregabalin | 15 | $157 | $10 |
| Tamsulosin | 12 | $139 | $12 |
2022: 47 drugs
| Eliquis | 21 | $29,279 | $1,394 |
| Repatha Sureclick | 21 | $12,528 | $597 |
| Xarelto | 13 | $11,613 | $893 |
| Nexletol | 17 | $8,683 | $511 |
| Rosuvastatin | 100 | $3,339 | $33 |
| Ezetimibe | 33 | $2,023 | $61 |
| Atorvastatin | 168 | $1,753 | $10 |
| Doxazosin Mesylate | 38 | $1,584 | $42 |
| Comfort Ez Pen Needle | 15 | $1,348 | $90 |
| Albuterol Sulfate Hfa | 23 | $1,186 | $52 |
| Levothyroxine | 49 | $1,132 | $23 |
| Losartan | 114 | $1,025 | $9 |
| Amlodipine Besylate | 155 | $932 | $6 |
| Valsartan | 11 | $915 | $83 |
| Clopidogrel | 24 | $840 | $35 |
| Metoprolol | 28 | $800 | $29 |
| Olmesartan-Hydrochlorothiazide | 13 | $768 | $59 |
| Carvedilol | 43 | $725 | $17 |
| Lisinopril | 59 | $691 | $12 |
| Olmesartan Medoxomil | 16 | $634 | $40 |
| Hydrochlorothiazide | 79 | $590 | $7 |
| Potassium Chloride | 14 | $531 | $38 |
| Chlorthalidone | 37 | $504 | $14 |
| Fluticasone Propionate | 22 | $393 | $18 |
| Simvastatin | 26 | $393 | $15 |
| Alendronate | 23 | $393 | $17 |
| Pregabalin | 16 | $381 | $24 |
| Sertraline | 24 | $378 | $16 |
| Pantoprazole | 25 | $354 | $14 |
| Metformin | 36 | $345 | $10 |
| Gabapentin | 21 | $320 | $15 |
| Trazodone | 17 | $296 | $17 |
| Isosorbide Mononitrate Er | 12 | $267 | $22 |
| Spironolactone | 29 | $236 | $8 |
| Metformin Hcl Er | 22 | $223 | $10 |
| Topiramate | 11 | $217 | $20 |
| Tamsulosin | 20 | $213 | $11 |
| Pramipexole Dihydrochloride | 11 | $195 | $18 |
| Omeprazole | 16 | $173 | $11 |
| Oxycodone-Acetaminophen | 14 | $171 | $12 |
| Furosemide | 24 | $165 | $7 |
| Atenolol | 17 | $153 | $9 |
| Mirtazapine | 14 | $139 | $10 |
| Zolpidem | 15 | $118 | $8 |
| Famotidine | 13 | $107 | $8 |
| Triamcinolone Acetonide | 17 | $71 | $4 |
| Clonidine | 12 | $57 | $5 |
2021: 42 drugs
| Eliquis | 11 | $16,126 | $1,466 |
| Januvia | 13 | $11,876 | $914 |
| Repatha Sureclick | 21 | $11,651 | $555 |
| Advair Diskus | 11 | $6,644 | $604 |
| Myrbetriq | 12 | $5,294 | $441 |
| Nexletol | 11 | $3,717 | $338 |
| Rosuvastatin | 72 | $3,599 | $50 |
| Atorvastatin | 164 | $2,081 | $13 |
| Ezetimibe | 29 | $1,921 | $66 |
| Losartan | 121 | $1,719 | $14 |
| Doxazosin Mesylate | 32 | $1,470 | $46 |
| Ventolin Hfa | 12 | $1,399 | $117 |
| Valsartan | 11 | $1,376 | $125 |
| Levothyroxine | 52 | $1,125 | $22 |
| Comfort Ez Pen Needle | 11 | $988 | $90 |
| Amlodipine Besylate | 133 | $855 | $6 |
| Hydrochlorothiazide | 94 | $799 | $8 |
| Olmesartan Medoxomil | 18 | $718 | $40 |
| Alendronate | 36 | $664 | $18 |
| Metoprolol | 32 | $613 | $19 |
| Azelastine | 13 | $501 | $39 |
| Albuterol Sulfate Hfa | 11 | $469 | $43 |
| Pantoprazole | 26 | $467 | $18 |
| Metformin | 27 | $407 | $15 |
| Lisinopril | 47 | $404 | $9 |
| Fluticasone Propionate | 23 | $383 | $17 |
| Chlorthalidone | 18 | $373 | $21 |
| Metformin Hcl Er | 15 | $328 | $22 |
| Gabapentin | 29 | $313 | $11 |
| Sertraline | 13 | $269 | $21 |
| Simvastatin | 41 | $247 | $6 |
| Omeprazole | 17 | $235 | $14 |
| Tamsulosin | 20 | $234 | $12 |
| Pramipexole Dihydrochloride | 11 | $231 | $21 |
| Carvedilol | 17 | $228 | $13 |
| Spironolactone | 36 | $226 | $6 |
| Furosemide | 28 | $173 | $6 |
| Atenolol | 20 | $166 | $8 |
| Trazodone | 20 | $156 | $8 |
| Clopidogrel | 15 | $155 | $10 |
| Fluoxetine | 15 | $99 | $7 |
| Clonidine | 17 | $67 | $4 |
2020: 41 drugs
| Eliquis | 16 | $20,361 | $1,273 |
| Repatha Sureclick | 17 | $13,498 | $794 |
| Xarelto | 16 | $13,118 | $820 |
| Myrbetriq | 12 | $5,012 | $418 |
| Advair Diskus | 14 | $4,598 | $328 |
| Rosuvastatin | 55 | $3,193 | $58 |
| Atorvastatin | 151 | $2,023 | $13 |
| Ventolin Hfa | 19 | $1,911 | $101 |
| Losartan | 115 | $1,490 | $13 |
| Doxazosin Mesylate | 20 | $1,485 | $74 |
| Levothyroxine | 44 | $1,165 | $26 |
| Ezetimibe | 26 | $1,110 | $43 |
| Propranolol | 15 | $880 | $59 |
| Metoprolol | 33 | $811 | $25 |
| Amlodipine Besylate | 118 | $724 | $6 |
| Potassium Chloride | 12 | $537 | $45 |
| Alendronate | 36 | $533 | $15 |
| Hydrochlorothiazide | 76 | $512 | $7 |
| Quinapril | 15 | $485 | $32 |
| Carvedilol | 46 | $420 | $9 |
| Lisinopril | 60 | $411 | $7 |
| Azelastine | 11 | $409 | $37 |
| Duloxetine | 12 | $408 | $34 |
| Fluticasone Propionate | 26 | $406 | $16 |
| Diclofenac | 12 | $314 | $26 |
| Gabapentin | 27 | $307 | $11 |
| Simvastatin | 51 | $299 | $6 |
| Metformin | 37 | $286 | $8 |
| Sertraline | 21 | $278 | $13 |
| Pantoprazole | 32 | $260 | $8 |
| Metformin Hcl Er | 18 | $218 | $12 |
| Triamcinolone Acetonide | 15 | $216 | $14 |
| Olmesartan Medoxomil | 16 | $200 | $13 |
| Spironolactone | 27 | $197 | $7 |
| Clonidine | 21 | $153 | $7 |
| Clopidogrel | 12 | $149 | $12 |
| Atenolol | 12 | $124 | $10 |
| Trazodone | 18 | $107 | $6 |
| Furosemide | 24 | $106 | $4 |
| Metoprolol | 13 | $73 | $6 |
| Omeprazole | 12 | $44 | $4 |
2019: 42 drugs
| Eliquis | 14 | $15,686 | $1,120 |
| Xarelto | 18 | $13,870 | $771 |
| Janumet Xr | 13 | $7,737 | $595 |
| Advair Diskus | 20 | $7,070 | $353 |
| Flovent Hfa | 13 | $3,300 | $254 |
| Rosuvastatin | 85 | $3,249 | $38 |
| Atorvastatin | 146 | $2,609 | $18 |
| Clonidine | 28 | $2,119 | $76 |
| Losartan | 142 | $1,655 | $12 |
| Metoprolol | 34 | $1,600 | $47 |
| Doxazosin Mesylate | 22 | $1,478 | $67 |
| Potassium Chloride | 20 | $1,339 | $67 |
| Ventolin Hfa | 13 | $1,334 | $103 |
| Amlodipine Besylate | 135 | $1,084 | $8 |
| Ezetimibe | 31 | $1,047 | $34 |
| Levothyroxine | 43 | $1,017 | $24 |
| Hydrochlorothiazide | 101 | $890 | $9 |
| Voltaren | 15 | $825 | $55 |
| Azelastine | 13 | $793 | $61 |
| Valsartan | 11 | $731 | $66 |
| Lisinopril | 69 | $666 | $10 |
| Duloxetine | 17 | $492 | $29 |
| Olmesartan Medoxomil | 16 | $470 | $29 |
| Carvedilol | 50 | $440 | $9 |
| Alendronate | 32 | $424 | $13 |
| Simvastatin | 49 | $410 | $8 |
| Esomeprazole Magnesium | 17 | $400 | $24 |
| Metformin | 36 | $381 | $11 |
| Omeprazole | 26 | $355 | $14 |
| Tamsulosin | 18 | $332 | $18 |
| Pantoprazole | 23 | $326 | $14 |
| Gabapentin | 25 | $312 | $12 |
| Pravastatin | 14 | $307 | $22 |
| Sertraline | 17 | $229 | $13 |
| Triamcinolone Acetonide | 22 | $204 | $9 |
| Spironolactone | 20 | $195 | $10 |
| Fluticasone Propionate | 17 | $187 | $11 |
| Clonidine | 31 | $186 | $6 |
| Atenolol | 17 | $148 | $9 |
| Nitroglycerin | 12 | $138 | $12 |
| Trazodone | 22 | $100 | $5 |
| Cyclobenzaprine | 14 | $73 | $5 |
2018: 42 drugs
| Xarelto | 24 | $16,142 | $673 |
| Lyrica | 13 | $8,687 | $668 |
| Flovent Hfa | 14 | $3,453 | $247 |
| Potassium Chloride | 21 | $2,586 | $123 |
| Atorvastatin | 125 | $2,283 | $18 |
| Ezetimibe | 27 | $2,232 | $83 |
| Rosuvastatin | 54 | $2,169 | $40 |
| Ventolin Hfa | 15 | $1,633 | $109 |
| Valsartan | 20 | $1,381 | $69 |
| Metoprolol | 45 | $1,296 | $29 |
| Azelastine | 19 | $1,157 | $61 |
| Levothyroxine | 33 | $1,014 | $31 |
| Losartan | 89 | $913 | $10 |
| Doxazosin Mesylate | 24 | $872 | $36 |
| Amlodipine Besylate | 121 | $759 | $6 |
| Hydrochlorothiazide | 130 | $704 | $5 |
| Lisinopril | 72 | $657 | $9 |
| Propranolol | 14 | $631 | $45 |
| Gabapentin | 32 | $543 | $17 |
| Oxycodone-Acetaminophen | 12 | $512 | $43 |
| Metformin | 50 | $447 | $9 |
| Nifedipine Er | 18 | $420 | $23 |
| Tamsulosin | 13 | $393 | $30 |
| Pravastatin | 16 | $372 | $23 |
| Simvastatin | 52 | $327 | $6 |
| Alendronate | 30 | $287 | $10 |
| Fluticasone Propionate | 16 | $267 | $17 |
| Carvedilol | 17 | $205 | $12 |
| Warfarin | 11 | $196 | $18 |
| Ranitidine | 12 | $194 | $16 |
| Fluoxetine | 12 | $188 | $16 |
| Spironolactone | 17 | $179 | $11 |
| Pantoprazole | 17 | $164 | $10 |
| Cyclobenzaprine | 14 | $138 | $10 |
| Atenolol | 16 | $128 | $8 |
| Omeprazole | 17 | $127 | $7 |
| Lisinopril-Hydrochlorothiazide | 13 | $122 | $9 |
| Zolpidem | 13 | $115 | $9 |
| Trazodone | 22 | $107 | $5 |
| Furosemide | 25 | $83 | $3 |
| Triamcinolone Acetonide | 12 | $66 | $6 |
| Clonidine | 11 | $50 | $5 |
2017: 39 drugs
| Xarelto | 17 | $12,882 | $758 |
| Lyrica | 13 | $6,221 | $479 |
| Metformin Hcl Er | 12 | $5,490 | $458 |
| Lantus | 12 | $3,067 | $256 |
| Rosuvastatin | 38 | $2,469 | $65 |
| Atorvastatin | 116 | $2,170 | $19 |
| Ezetimibe | 12 | $1,253 | $104 |
| Chlorthalidone | 23 | $868 | $38 |
| Amlodipine Besylate | 92 | $770 | $8 |
| Metoprolol | 26 | $738 | $28 |
| Propranolol | 17 | $720 | $42 |
| Valsartan | 20 | $685 | $34 |
| Losartan | 82 | $675 | $8 |
| Doxazosin Mesylate | 15 | $561 | $37 |
| Levothyroxine | 16 | $549 | $34 |
| Oxycodone-Acetaminophen | 15 | $499 | $33 |
| Metformin | 41 | $414 | $10 |
| Gabapentin | 30 | $401 | $13 |
| Pravastatin | 13 | $381 | $29 |
| Potassium Chloride | 14 | $379 | $27 |
| Lisinopril | 54 | $342 | $6 |
| Warfarin | 11 | $313 | $28 |
| Alendronate | 43 | $311 | $7 |
| Simvastatin | 52 | $306 | $6 |
| Hydrochlorothiazide | 53 | $293 | $6 |
| Tamsulosin | 15 | $285 | $19 |
| Fluticasone Propionate | 17 | $281 | $17 |
| Ranitidine | 12 | $218 | $18 |
| Spironolactone | 20 | $205 | $10 |
| Carvedilol | 29 | $193 | $7 |
| Sertraline | 19 | $158 | $8 |
| Clonidine | 25 | $137 | $5 |
| Cyclobenzaprine | 12 | $107 | $9 |
| Atenolol | 19 | $105 | $6 |
| Zolpidem | 16 | $95 | $6 |
| Omeprazole | 12 | $92 | $8 |
| Trazodone | 15 | $80 | $5 |
| Pantoprazole | 12 | $62 | $5 |
| Clonazepam | 12 | $53 | $4 |
2016: 45 drugs
| Crestor | 23 | $11,205 | $487 |
| Bystolic | 20 | $2,093 | $105 |
| Candesartan Cilexetil | 12 | $1,702 | $142 |
| Atorvastatin | 98 | $1,672 | $17 |
| Duloxetine | 16 | $1,500 | $94 |
| Lidocaine | 12 | $1,470 | $123 |
| Metoprolol | 37 | $1,416 | $38 |
| Ventolin Hfa | 17 | $1,168 | $69 |
| Valsartan | 26 | $1,053 | $40 |
| Chlorthalidone | 33 | $924 | $28 |
| Propranolol | 24 | $916 | $38 |
| Pravastatin | 34 | $840 | $25 |
| Gabapentin | 27 | $746 | $28 |
| Doxazosin Mesylate | 23 | $709 | $31 |
| Levothyroxine | 26 | $623 | $24 |
| Losartan | 64 | $546 | $9 |
| Oxycodone-Acetaminophen | 17 | $481 | $28 |
| Simvastatin | 73 | $464 | $6 |
| Amlodipine Besylate | 69 | $453 | $7 |
| Lisinopril | 60 | $446 | $7 |
| Tamsulosin | 21 | $396 | $19 |
| Hydrochlorothiazide | 61 | $379 | $6 |
| Potassium Chloride | 11 | $291 | $26 |
| Spironolactone | 17 | $291 | $17 |
| Metformin | 46 | $277 | $6 |
| Alendronate | 33 | $261 | $8 |
| Fluticasone Propionate | 21 | $260 | $12 |
| Finasteride | 18 | $224 | $12 |
| Sertraline | 22 | $212 | $10 |
| Omeprazole | 26 | $201 | $8 |
| Glimepiride | 13 | $201 | $15 |
| Carvedilol | 28 | $200 | $7 |
| Meclizine | 12 | $194 | $16 |
| Pioglitazone | 15 | $190 | $13 |
| Metoprolol | 21 | $165 | $8 |
| Zolpidem | 19 | $159 | $8 |
| Donepezil | 15 | $121 | $8 |
| Triamterene-Hydrochlorothiazid | 12 | $117 | $10 |
| Tramadol | 16 | $95 | $6 |
| Atenolol | 15 | $89 | $6 |
| Clonazepam | 12 | $79 | $7 |
| Citalopram Hbr | 13 | $76 | $6 |
| Trazodone | 13 | $65 | $5 |
| Clonidine | 11 | $58 | $5 |
| Furosemide | 15 | $56 | $4 |
2015: 36 drugs
| Crestor | 24 | $11,240 | $468 |
| Lantus | 11 | $2,841 | $258 |
| Lidocaine | 13 | $2,535 | $195 |
| Valsartan | 24 | $2,215 | $92 |
| Atorvastatin | 55 | $1,417 | $26 |
| Metoprolol | 19 | $984 | $52 |
| Clopidogrel | 22 | $979 | $44 |
| Pravastatin | 41 | $875 | $21 |
| Hydrocodone-Acetaminophen | 18 | $855 | $47 |
| Propranolol | 34 | $811 | $24 |
| Levothyroxine | 17 | $638 | $38 |
| Doxazosin Mesylate | 19 | $630 | $33 |
| Gabapentin | 20 | $578 | $29 |
| Lisinopril | 64 | $532 | $8 |
| Fluticasone Propionate | 46 | $506 | $11 |
| Tamsulosin | 21 | $490 | $23 |
| Losartan | 45 | $487 | $11 |
| Simvastatin | 59 | $409 | $7 |
| Flecainide Acetate | 14 | $400 | $29 |
| Omeprazole | 27 | $320 | $12 |
| Amlodipine Besylate | 53 | $295 | $6 |
| Alendronate | 26 | $285 | $11 |
| Zolpidem | 33 | $274 | $8 |
| Metformin | 43 | $261 | $6 |
| Finasteride | 22 | $239 | $11 |
| Hydrochlorothiazide | 32 | $238 | $7 |
| Sertraline | 25 | $207 | $8 |
| Spironolactone | 24 | $194 | $8 |
| Pioglitazone | 15 | $194 | $13 |
| Glimepiride | 15 | $193 | $13 |
| Carvedilol | 33 | $188 | $6 |
| Furosemide | 13 | $111 | $9 |
| Metoprolol | 14 | $98 | $7 |
| Clonazepam | 14 | $95 | $7 |
| Donepezil | 14 | $90 | $6 |
| Tramadol | 16 | $87 | $5 |
2014: 34 drugs
| Crestor | 17 | $6,916 | $407 |
| Diovan | 26 | $6,128 | $236 |
| Duloxetine | 12 | $2,906 | $242 |
| Metoprolol | 25 | $1,516 | $61 |
| Lidocaine | 13 | $1,254 | $96 |
| Atorvastatin | 44 | $1,216 | $28 |
| Clopidogrel | 18 | $1,115 | $62 |
| Pravastatin | 45 | $1,103 | $25 |
| Isosorbide Dinitrate | 11 | $1,036 | $94 |
| Doxazosin Mesylate | 14 | $956 | $68 |
| Hydrocodone-Acetaminophen | 17 | $796 | $47 |
| Losartan | 44 | $763 | $17 |
| Simvastatin | 65 | $741 | $11 |
| Propranolol | 28 | $682 | $24 |
| Donepezil | 15 | $658 | $44 |
| Flecainide Acetate | 16 | $629 | $39 |
| Fluticasone Propionate | 26 | $591 | $23 |
| Lisinopril | 57 | $588 | $10 |
| Levothyroxine | 16 | $474 | $30 |
| Metformin | 40 | $402 | $10 |
| Tamsulosin | 23 | $397 | $17 |
| Omeprazole | 35 | $387 | $11 |
| Carvedilol | 35 | $292 | $8 |
| Amlodipine Besylate | 35 | $290 | $8 |
| Alendronate | 25 | $259 | $10 |
| Zolpidem | 28 | $252 | $9 |
| Allopurinol | 19 | $243 | $13 |
| Pioglitazone | 12 | $230 | $19 |
| Trazodone | 23 | $200 | $9 |
| Finasteride | 21 | $191 | $9 |
| Hydrochlorothiazide | 40 | $152 | $4 |
| Metoprolol | 16 | $126 | $8 |
| Furosemide | 18 | $116 | $6 |
| Triamcinolone Acetonide | 14 | $88 | $6 |
2013: 32 drugs
| Crestor | 25 | $6,592 | $264 |
| Donepezil | 16 | $1,755 | $110 |
| Metoprolol | 22 | $1,751 | $80 |
| Atorvastatin | 33 | $1,195 | $36 |
| Losartan | 81 | $1,138 | $14 |
| Simvastatin | 98 | $1,074 | $11 |
| Fluticasone Propionate | 31 | $921 | $30 |
| Propranolol | 34 | $791 | $23 |
| Gabapentin | 21 | $770 | $37 |
| Felodipine Er | 15 | $763 | $51 |
| Lisinopril | 73 | $701 | $10 |
| Doxazosin Mesylate | 19 | $546 | $29 |
| Hydrochlorothiazide | 56 | $421 | $8 |
| Pravastatin | 20 | $407 | $20 |
| Omeprazole | 32 | $392 | $12 |
| Tamsulosin | 17 | $353 | $21 |
| Amlodipine Besylate | 33 | $344 | $10 |
| Hydrocodone-Acetaminophen | 15 | $338 | $23 |
| Levothyroxine | 21 | $301 | $14 |
| Metformin | 24 | $274 | $11 |
| Carvedilol | 32 | $273 | $9 |
| Alendronate | 15 | $229 | $15 |
| Trazodone | 21 | $219 | $10 |
| Lovastatin | 16 | $214 | $13 |
| Metoprolol | 17 | $192 | $11 |
| Furosemide | 16 | $144 | $9 |
| Allopurinol | 19 | $138 | $7 |
| Triamcinolone Acetonide | 19 | $134 | $7 |
| Atenolol | 27 | $131 | $5 |
| Zolpidem | 28 | $120 | $4 |
| Finasteride | 11 | $112 | $10 |
| Doxepin | 11 | $88 | $8 |
Money from drug and device companies
$190 in 2025
| 2025 | 2 | 3 | None | $190 |
| 2024 | 1 | 1 | None | $129 |
| 2020 | 1 | 1 | $520 | $520 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Idorsia Pharmaceuticals US | Tryvio | $122 | 2 payments
|
| Esperion Therapeutics | Nexletol | $68 | 1 payment
|
See all 3 published payments
| Idorsia Pharmaceuticals US | Meals · 2025-08-08 | Tryvio | $27 |
| Esperion Therapeutics | Meals · 2025-08-01 | Nexletol | $68 |
| Idorsia Pharmaceuticals US | Meals · 2025-07-22 | Tryvio | $95 |
See earlier years (2024, 2020)
2024: $129
| Medtronic | Symplicity G3 | $129 | 1 payment
|
2020: $520
| Bayer HealthCare Pharmaceuticals | Non-Covered | $520 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Cleerly, Inc. · Transform · 2025 | Their institution | $21,831 |
Professional record
- NPI
- 1083717359
- Licence
- CA A65925California A65925: Current · expires 2027-11-30
- Trained
- University of Texas Southwestern Medical School at Dallas, 1995
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-09-05
- NPI last updated
- 2024-04-24
- NPI record certified
- 2024-04-24
This is when the NPI record was last certified, not a medical board exam.